Aurobindo Pharma Limited (NSE:AUROPHARMA)
India · Delayed Price · Currency is INR 1,304.40
-9.80 (-0.75%)
At close: Mar 30, 2026
Aurobindo Pharma Market Cap
Aurobindo Pharma has a market cap or net worth of 757.6 billion as of March 30, 2026. Its market cap has increased by 18.86% in one year.
Market Cap
757.60B
Enterprise Value
746.55B
Revenue
331.82B
Ranking
n/a
PE Ratio
21.73
Stock Price
1,304.40
Market Cap Chart
Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 757.60B, an increase of 7,788.95%. That is a compound annual growth rate of 20.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 757.60B | 10.26% |
| Dec 31, 2025 | 687.09B | -11.35% |
| Dec 31, 2024 | 775.08B | 22.03% |
| Dec 29, 2023 | 635.16B | 147.32% |
| Dec 30, 2022 | 256.82B | -40.31% |
| Dec 31, 2021 | 430.28B | -20.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.59T |
| Cipla | 1.00T |
| Zydus Lifesciences | 902.29B |
| Mankind Pharma | 841.67B |
| Alkem Laboratories | 639.02B |
| Glenmark Pharmaceuticals | 612.52B |
| Laurus Labs | 544.61B |
| Ipca Laboratories | 402.37B |